系统性硬化症早期识别迈进一步:莱顿CCISS队列数据
本研究基于莱顿CCISS队列643例符合ACR/EULAR 2013年SSc分类标准的患者,按入组年份分为2010-2013年、2014-2017年和2018-2021年三组,评估早期识别是否随时间改善及疾病特征与生存变化。结果显示症状发作至入组间隔缩短、指端溃疡及临床意义ILD和dcSSc比例下降,男性8年生存率59%持续低于女性89%。
要点
- 症状发作至队列入组时间随时间缩短,但女性始终长于男性。
- ACA阳性者几乎不出现ILD,ATA阳性者ILD比例由2010-2013年25%降至2018-2021年19%。
- 男性8年生存率59%(95%CI 40%至73%)低于女性89%(95%CI 82%至93%)。
核心结论
- 莱顿CCISS队列入组时疾病 duration 缩短,可能提示SSc诊断更及时,或为早期干预提供机会。
- 女性就诊时症状持续时间更长,但男性死亡率始终更高,作者强调需要性别特异性的治疗和随访。
研究设计与样本
- 研究纳入643例符合ACR/EULAR 2013年SSc分类标准的SSc患者,按队列入组年份分为三组:2010-2013年229例(36%)、2014-2017年207例(32%)、2018-2021年207例(32%)。
- 比较变量包括疾病持续时间、间质性肺病(ILD)、指端溃疡(DU)、弥漫性皮肤型SSc(dcSSc)、抗拓扑异构酶(ATA)和抗着丝点(ACA)抗体,以及自疾病发作起的生存,并包括按性别和自身抗体分层的分析。
主要发现
- 随时间推移,男性和女性从症状发作到队列入组的时间间隔均缩短,但女性始终长于男性。
- 出现指端溃疡的患者比例下降,尤其在ACA阳性SSc患者中。
- ACA阳性患者几乎不出现ILD,而ATA阳性患者中ILD比例在2010-2013年为25%,2018-2021年降至19%。
- 出现临床意义ILD和dcSSc的患者比例下降。
- 男性总体8年生存率为59%(95%CI 40%至73%),女性为89%(95%CI 82%至93%);8年生存率随时间呈改善趋势,且男性始终更差。
关键数值与推荐
- SSc诊断标准为ACR/EULAR 2013年SSc分类标准。
- ATA阳性患者ILD比例:2010-2013年25%,2018-2021年19%。
- 8年生存率:男性59%(95%CI 40%至73%),女性89%(95%CI 82%至93%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Since 2009, Dutch patients with a confirmed diagnosis/suspicion of systemic sclerosis (SSc) can be referred to the Leiden Combined Care in Systemic Sclerosis (CCISS) cohort. This study evaluated whether early recognition of SSc has improved over time and whether disease characteristics and survival has changed over time. METHODS: 643 SSc patients fulfilling American College of Rheumatology/European Alliance of Associations for Rheumatology 2013 SSc criteria were included and categorised into three groups based on cohort-entry year: (1) 2010-2013 (n=229 (36%)), (2) 2014-2017 (n=207 (32%)) and (3) 2018-2021 (n=207 (32%)). Variables including disease duration, interstitial lung disease (ILD), digital ulcers (DU), diffuse cutaneous SSc (dcSSc), antitopoisomerase (ATA) and anticentromere (ACA) antibodies, and survival from disease onset were compared between cohort-entry groups, including analyses stratified for sex and autoantibodies. RESULTS: Over time, duration between onset of disease symptoms and cohort entry decreased in males and females, but was always longer in females than in males.The proportion of patients presenting with DU decreased, especially in ACA+SSc patients. Almost no ACA+ patients presented with ILD, while in ATA+ patients this proportion was 25% in 2010-2013 and decreased to 19% in 2018-2021. A reduction in patients presenting with clinically meaningful ILD and dcSSc was observed.Overall 8-year survival for males was 59% (95% CI 40% to 73%) and for females 89% (95% CI 82% to 93%). Eight-year survival showed a trend for improvement over time, and was always worse in males. CONCLUSION: We observed a decrease in disease duration in Leiden CCISS cohort at cohort entry, possibly indicating more timely diagnosis of SSc. This could provide opportunities for early interventions. While symptom duration at presentation is longer in females, mortality is consistently higher in males, underlining the urge for sex-specific treatment and follow-up.
引用
- Liem SIE, Ciaffi J, van Leeuwen NM, et al. Step forward in early recognition of systemic sclerosis: data from the Leiden CCISS cohort. RMD Open. 2023. PMID: 37028816. doi:10.1136/rmdopen-2022-002971
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。